Clinical Social Workers in Washington Depot, CT Accepting Medicare
2 Clinical Social Workers found. Showing 1 - 2
 Mr. Peter Marc Schoenholtz, L.C.S.W. Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 12 Titus Rd, Washington Depot, CT 06794 Phone: 860-868-1181 Fax: 860-868-1181 |
 Katherine Louise Merrill, LCSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 10 Brinsmaid Rd, Washington Depot, CT 06794 Phone: 203-805-9477 |
News Archive
Ticks abound both sides of the Atlantic
Ticks are making their presence felt both sides of the Atlantic. The British public is being warned to take precautions against ticks following a rise in the tick population after a wet and mild summer
Cook Medical launches FluoroSet for accurate fluoroscopic evaluation results
Approximately one million women in the United States are rendered infertile by disease in the fallopian tubes, the most common being tubal occlusion or blockage. This condition is commonly diagnosed using a complicated, invasive fluoroscopic evaluation, consisting of real-time, action images of the fallopian tubes to identify possible occlusions. In an effort to simplify this procedure and ease patient discomfort, Cook Medical today announced the availability of the FluoroSet, a comprehensive, three-product radiographic tubal assessment set designed to deliver fast, easy, accurate fluoroscopic evaluation results.
Hydrogel capsule could simultaneously deliver different types of drugs
Researchers at the Georgia Institute of Technology have designed a multiple-compartment gel capsule that could be used to simultaneously deliver drugs of different types. The researchers used a simple "one-pot" method to prepare the hydrogel capsules, which measure less than one micron.
FDA approves Teva's ProAir HFA with dose counter for asthma, COPD and EIB
Teva Respiratory announced today that the U.S. Food and Drug Administration (FDA) has approved ProAir HFA with a dose counter for use in patients 4 years of age and older for the treatment or prevention of bronchospasm with reversible obstructive airway disease and for the prevention of exercise-induced bronchospasm.
Circassia: House dust mite allergy treatment meets primary endpoint in phase II clinical study
Circassia Ltd, a specialty biopharmaceutical company focused on allergy, today announced successful results from a phase II clinical study of its house dust mite allergy treatment (House Dust Mite-Synthetic Peptide Immuno-Regulatory Epitope [HDM-SPIRE] based on Circassia's ToleroMune technology).
› Verified 5 days ago